General Updates

June 30, 2026 BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25th Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maharashtra, India BSE Scrip Code: 544309 NSE Symbol: IKS Dear Sir/Ma’am, Sub: Investors’ Frequently Asked Questions (FAQs) – WWMG Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the investors’ FAQs with respect to the announcement, “Additional investment in IKS WWMG MSO LLC, an associate company of Inventurus Knowledge Solutions Inc (“IKS Inc”), a wholly owned subsidiary of the Company.” The said FAQs is also being uploaded on the website of the Company at the https://ikshealth.com/investor-relations/ Request you to take it on record and disseminate it on your website. Thanking you. Yours sincerely, For Inventurus Knowledge Solutions Limited Sameer Chavan Company Secretary and Compliance Officer Membership No. F7211 Encl: As above Investor FAQ: WWMG 1. What is this investment going into the MSO? What are the uses of cash? • A total equity infusion of $15 million has been approved until March 31, 2029, which will result in IKS becoming the majority owner with an immediate investment of $3 million upto 3rd July 2026. • The strategic allocation of this capital is for strategic growth initiatives, including physician hiring, Value-Based Care (VBC) expansion, and general working capital support. • This capital injection is designed to facilitate the expansion of the physician practice. Currently, 13 recently acquired physicians are in their initial ramp-up stage, with recruitment for an additional nine doctors slated for the coming 6 months. The organization anticipates growth as these clinical practices reach maturity, leading to increased operating leverage and a projected rise in IKS platform services revenue. 2. How is the implementation of the platform progressing? • Platform adoption is nearly complete following the resolution of initial Epic access challenges. • As of June 2026, 95% clinicians have been successfully onboarded onto the Scribble platform. Key technologies such as the Virtual Clinic Assistant, Referral Management, and My Care Hub are operational. Ongoing technical specification updates are in progress to resolve remaining data compatibility issues for EVE - Prior Authorization. 3. What is the current quantum of investment? • The total investment by IKS which stands at $17 million today is expected to reach $32 million by 2029. The immediate near term investment is ~5mn. 4. How is the investment in WWMG playing out compared to your expectations? • While the platform implementation was delayed due to an initial Epic access issue, the investment is panning out as on expected lines, with visible green shoots on various parameters. The organisation has acquired 13 new providers in the last six months and plans to acquire 9 providers in the next 6 months. On the existing providers, we are able to see improvement in the performance as the platform is being implemented. • Operational Efficiency: Revenue Cycle Management (RCM) optimization has successfully reduced Days Sales Outstanding (DSO) from 46.1 days to 41.7 days. • Cost Management: The organization has taken actions that will result in $2.5 million dollars of annualised savings in the upcoming year. • Performance Growth: Visit counts increased by 3% from April to May 2026 as platform implementation accelerated. Additionally, all VBC agreements have been renegotiated to contribute to future revenue growth. • Our return on investment is along expected lines and in line with our overall business ROE. WWMG continues to be a top 10 customer for IKS. 5. What are the intangible and strategic benefits of the WWMG partnership? • WWMG serves as a powerful brand ambassador and reference site, enhancing market credibility. • WWMG’s endorsement directly facilitated securing full platform deals with similar physician-led multi-speciality groups, helping validate the unified solution model. • Acting as a premier partner, WWMG has enabled the organization to obtain a license as an Accountable Care Organization (ACO) convenor.